Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Aarti Drugs Limited is one of the leading pharma companies in India .The company manufactures over 40 products comprising of bulk actives, key intermediates, and specialty chemicals. Its product portfolio includes anti-biotic, anti-protozoal, anti-inflammatory, anti-fungal, anti-diabetic, cardio-protectant, vitamins, anti-arthritis, sedatives therapeutic groups that help in lifesaving and lifestyle related diseases .
The Company has nine manufacturing locations located at Tarapur (Maharashtra) and two manufacturing locations located at Sarigam (Gujarat), most of them being GMP certified . The company exports its products to over 100 countrie s worldwide.
| Issue Period | April 27, 2021 - May 10, 2021 |
| Security Name | Aarti Drugs Limited |
| Issue Type | Tender Offer |
| Issue Size (Shares) | 600,000 |
| Issue Size (Amount) | ₹60.00 Crores |
| Buyback Price | ₹1000 per share |
| Face Value | ₹10 per share |
| Listing At | BSE, NSE |
| Record Date | April 1, 2021 |
| Offer Opens On | April 27, 2021 |
| Last Date for receipt of Tender Forms | May 12, 2021 |
| Offer Closes On * | May 10, 2021 |
| Finalisation of Buyback Acceptance | May 19, 2021 |
| Last Date for settlment of bids | May 20, 2021 |
| Last Date for Extinguishment of Shares | May 27, 2021 |
| Category | Entitlement Ratio of Buyback |
|---|---|
| Reserved Category for Small Shareholders | 8 Equity Shares out of every 569 paid-up Equity Shares held on the Record Date. |
| General Category for all other Eligible Shareholders | 5 Equity Shares out of every 851 paid-up Equity Shares held on the Record Date. |
| Particulars | For the year/period ended (Rs. in Millions) | ||
|---|---|---|---|
| 31-Mar-20 | 31-Mar-19 | 31-Mar-18 | |
| Total Income | 18,075.71 | 15,671.17 | 12,636.18 |
| Profit After Tax | 1,413.99 | 897.52 | 823.07 |
| Net Worth | 6,467.45 | 5,373.09 | 4,502.79 |
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Feb-2021 | 694.95 | 625.00 | 658.87 |
| Jan-2021 | 755.50 | 670.05 | 710.03 |
| Dec-2021 | 812.00 | 645.00 | 741.25 |
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Feb-2021 | 695.00 | 628.00 | 658.75 |
| Jan-2021 | 756.00 | 670.00 | 710.11 |
| Dec-2021 | 811.00 | 645.65 | 741.17 |
The Buyback aims to :
i) Service the equity more efficiently.
ii) Return surplus cash to the shareholders.
ii) Improve Return on Equity
iii) Improve earnings per share and thus increase the shareholder's value in the long-term.
8 4.3 Rating:  Vote Here ... |
Sorry, we couldn't find any reviews, please check back later.
Aarti Drugs Limited
Plot No. – N-198,
M.I.D.C., Village - Pamtermbhi
Taluka & Dist. Palghar - 401 506
Phone: +91 22 2404 8199
Email: investorrelations@aartidrugs.com
Website: https://www.aartidrugs.co.in/
Link Intime India Private Ltd
Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai - 400083
Phone: +91-22-4918 6270
Email: aartidrugs.buyback2021@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
Lead Manager(s)
Registered Broker
The Aarti Drugs Buyback opens on April 27, 2021, and closes on May 10, 2021.
The Aarti Drugs Buyback last day to buy is not available as of now.
The Aarti Drugs Buyback is a Tender Offer.
Aarti Drugs Buyback Schedule
| Buyback Opening Date | April 27, 2021 |
| Buyback Closing Date | May 10, 2021 |
| Last Date for receipt of Tender Forms | May 12, 2021 |
| Finalisation of Buyback Acceptance | May 19, 2021 |
| Last Date for settlment of bids | May 20, 2021 |
| Last Date for Extinguishment of Shares | May 27, 2021 |
The Aarti Drugs Buyback is being offered at Rs ₹1000 per share per equity share.
| Category | Entitlement Ratio of Buyback |
|---|---|
| Reserved Category for Small Shareholders | 8 Equity Shares out of every 569 paid-up Equity Shares held on the Record Date. |
| General Category for all other Eligible Shareholders | 5 Equity Shares out of every 851 paid-up Equity Shares held on the Record Date. |
The record date for the Aarti Drugs Buyback is April 1, 2021.
The issue size of Aarti Drugs Buyback is of 600,000 equity shares at ₹1000 per share aggregating upto ₹60.00 Crores.
The Buyback aims to :
i) Service the equity more efficiently.
ii) Return surplus cash to the shareholders.
ii) Improve Return on Equity
iii) Improve earnings per share and thus increase the shareholder's value in the long-term.
All the eligible Shareholders of the Company holding either Physical Shares or Demat Shares as on the Record Date can participate in the buyback offer through their Stock Broker.
The eligible shareholder holding the shares in Demat form needs to inform their broker the details of the Equity shares they wish to tender in the Buyback Offer. The shareholder needs to transfer the tendered shares to a Special account of the clearing corporation. The broker, in turn, would place an order on the stock exchange for the buyback.
The eligible shareholder holding the shares in physical form needs to approach their broker with original share certificates and supporting documents. Upon completion of document verification, the broker places an order on the stock exchange and submits the original share certificate and TRS to the registrar.
The tender form and TRS are optional in the case of Demat shares but mandatory in the case of physical shares.
The Aarti Drugs Buyback offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
